FindTrial
Sign In

A clinical trial to study the effects of two drugs Dydrogesterone and micronized progesterone in pregnant women with threatened abortion

Comparison of oral Dydrogesterone and oral Micronized progesterone in reducing the risk of miscarriage in pregnant women with threatened abortion.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028244
Enrollment
100
Registered
2020-10-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O200- Threatened abortion

Interventions

Intervention1: dydrogesterone, micronized progesterone: dydrogesterone 40mg stat followed by 10mg twice a daytill 14 weeks, micronized progesterone 200mg twice daily till 14 weeks Intervention2: dupha

Sponsors

department of Obstetrics and gynaecology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Gestational age less than 12weeks of gestation in women with threatened abortion. Singleton intrauterine live pregnancy. Women aged from 20 to 35 years.

Exclusion criteria

Exclusion criteria: History of recurrent miscarriage (defined as at least three consecutive spontaneous miscarriages). History of cervical surgery. Heavy vaginal bleeding requiring surgical intervention. Any uterine anomalies. Any associated medical and surgical illness.

Design outcomes

Primary

MeasureTime frame
Miscarriage before 20 weeks of gestationTimepoint: Miscarriage rate, time points :20 weeks of gestation—

Secondary

MeasureTime frame
Live birth rate Period of gestational age at delivery Birth weight at delivery Antepartum haemorrhage Pre-eclampsia Timepoint: 20weeks to till delivery—

Countries

India

Contacts

Public ContactChinthala sai charishma

loknayak hospital

drkrishna.agarwal@gmail.com9871214208

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026